HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

'Secrets, Secrets, Are No Fun': California’s Fragrance Transparency Bill Heads For Senate Vote

Executive Summary

The Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2019 has cleared key Senate committees, including Appropriations, and is now up for a third read on the Senate floor.

You may also be interested in...



California Fragrance Disclosure Bill Headed For Assembly Vote With Time Running Out

The proposed Cosmetic Fragrance and Flavor Ingredient Right to Know Act faces no opposition in its current form, but must pass California’s Assembly and get the Senate’s concurrence before 1 September.

California Fragrance Disclosure Bill Screeches To Halt As Legislature Adjourns For Year; Now What?

Funding issues appear to have factored in the proposed Cosmetic Fragrance and Flavor Ingredient Right to Know Act’s failure to cross the finish line in the first act of the California legislature’s 2019-2020 session. Far from popular with industry stakeholders, SB 574 nevertheless could represent a lesser-of-evils compromise of strategic importance, with further activity expected on the bill in 2020.

California Fragrance Disclosure Bill Has Clearer Path To Governor With Industry Opposition Removed

Major industry advocates have dropped their formal objections to an amended California bill that would require use of questionable fragrance components in cosmetics to be reported to the state’s health department. The proposed legislation is moving rapidly through the California Assembly after passing the Senate in late May.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel